Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "2020"

633 News Found

NFHS-5 shows momentum towards achieving SDG
News | November 25, 2021

NFHS-5 shows momentum towards achieving SDG

The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues


ADB approves US $ 1.5 bn for Covid-19 vaccines in India
News | November 25, 2021

ADB approves US $ 1.5 bn for Covid-19 vaccines in India

The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people


Medical devices industry needs reforms:  Mehernosh Daruwalla, Founder & MD, Lotus Surgicals
interviews | November 24, 2021

Medical devices industry needs reforms: Mehernosh Daruwalla, Founder & MD, Lotus Surgicals

The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector


Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer
Hospitals | November 24, 2021

Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer

Cryo-technology helps in early diagnosis and palliative care in later stages of cancer


Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease
Biotech | November 23, 2021

Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease

The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis


CStone and Jiangsu Hengrui sign exclusive licensing agreement for cancer drugs in China
Biotech | November 22, 2021

CStone and Jiangsu Hengrui sign exclusive licensing agreement for cancer drugs in China

CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region


J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
News | November 12, 2021

J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22

J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021


Metropolis Healthcare PAT at Rs 58.26 cr in Q2FY22
News | November 11, 2021

Metropolis Healthcare PAT at Rs 58.26 cr in Q2FY22

Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021


Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania
News | November 11, 2021

Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania

The consideration for the acquisition is US $ 2.25 million


Marksons Pharma PAT slips to Rs 46.28 in Q2FY22
News | November 10, 2021

Marksons Pharma PAT slips to Rs 46.28 in Q2FY22

Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021